Skip to main content
. 2017 Apr 13;11(3):178–190. doi: 10.1097/ADM.0000000000000308

TABLE 3.

Materials Used to Inform Search Method 1

American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women; American Society of Addiction Medicine. Committee Opinion No. 524: Opioid Abuse, Dependence, and Addiction in Pregnancy, 2012. Available at: https://www.acog.org/-/media/Committee-Opinions/Committee-on-Health-Care-for-Underserved-Women/co524.pdf?dmc=1&ts=20160302T1440499290
American Society of Addiction Medicine. National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. Available at: http://www.asam.org/quality-practice/guidelines-and-consensus-documents/npg
Hudak ML, Tan RC; Committee On Drugs, Committee On Fetus And Newborn, American Academy of Pediatrics. Clinical report: neonatal drug withdrawal. Pediatrics 2012;129:e540–e560. Available at: http://pediatrics.aappublications.org/content/129/2/e540
Reece-Stremtan S, Marinelli KA; The Academy of Breastfeeding Medicine. ABM Clinical Protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med 2015;10:135–141. Available at: http://www.bfmed.org/Media/Files/Protocols/Guidelines%20for%20Breastfeeding%20and%20Substance%20Use%20or%20Use%20Disorder.pdf
World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Geneva, Switzerland: WHO Press; 2014. Available at: http://www.who.int/substance_abuse/publications/pregnancy_guidelines/en/